E. Huber / Ian Magrath (eds.)
Gene Therapy in the Treatment of Cancer
Progress and Prospects
Herausgeber: Huber, Brian E.; Sikora, Karol; Magrath, Ian T.
E. Huber / Ian Magrath (eds.)
Gene Therapy in the Treatment of Cancer
Progress and Prospects
Herausgeber: Huber, Brian E.; Sikora, Karol; Magrath, Ian T.
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Reviews progress and considers future developments in the fast-evolving field of gene therapy in oncology.
Andere Kunden interessierten sich auch für
- Herbert M. PinedoDrug Resistance in the Treatment of Cancer248,99 €
- Kirpal S. GulliyaNovel Chemotherapeutic Agents: Preactivation in the Treatment of Cancer and AIDS77,99 €
- Breast Cancer Radiation Therapy113,99 €
- Breast Cancer Radiation Therapy81,99 €
- Wolfgang Walther / Ulrike Stein (eds.)Gene Therapy of Cancer77,99 €
- The Science of Cancer Treatment39,99 €
- B.A. Ponder (ed.) / M.J. WaringThe Science of Cancer Treatment109,99 €
-
-
-
Reviews progress and considers future developments in the fast-evolving field of gene therapy in oncology.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 230
- Erscheinungstermin: 23. April 2014
- Englisch
- Abmessung: 235mm x 157mm x 17mm
- Gewicht: 492g
- ISBN-13: 9780521444361
- ISBN-10: 0521444365
- Artikelnr.: 22213151
- Verlag: Cambridge University Press
- Seitenzahl: 230
- Erscheinungstermin: 23. April 2014
- Englisch
- Abmessung: 235mm x 157mm x 17mm
- Gewicht: 492g
- ISBN-13: 9780521444361
- ISBN-10: 0521444365
- Artikelnr.: 22213151
Contributors
Preface
1. Introduction: gene therapy approaches to cancer Brian E. Huber
2. Principles of transformation-directed cancer therapy Ian Magrath and Kishor Bhatia
3. Vectors for cancer gene therapy Prem Seth
4. Genetically engineering drug sensitivity and drug resistance for the treatment of cancer Brian E. Huber
5. Oncogene inactivation and replacement strategies for cancer Jack A. Roth
6. Genetically modified tumor cells as tumor vaccines John C. Krauss, Suyu Shu and Alfred E. Chang
7. Genetically modified lymphocytes and hematopoietic stem cells as therapeutic vehicles Patrick J. Geraghty and James J. Mulé
8. Pharmacologic effects of oligonucleotides and some clinical applications Leonard M. Neckers and Kanak Iyer
9. Current status of gene marking and gene therapy in oncology clinical trials Cynthia A. Richards
10. Safety testing for gene therapy products J. Patrick Condreay
Index.
Preface
1. Introduction: gene therapy approaches to cancer Brian E. Huber
2. Principles of transformation-directed cancer therapy Ian Magrath and Kishor Bhatia
3. Vectors for cancer gene therapy Prem Seth
4. Genetically engineering drug sensitivity and drug resistance for the treatment of cancer Brian E. Huber
5. Oncogene inactivation and replacement strategies for cancer Jack A. Roth
6. Genetically modified tumor cells as tumor vaccines John C. Krauss, Suyu Shu and Alfred E. Chang
7. Genetically modified lymphocytes and hematopoietic stem cells as therapeutic vehicles Patrick J. Geraghty and James J. Mulé
8. Pharmacologic effects of oligonucleotides and some clinical applications Leonard M. Neckers and Kanak Iyer
9. Current status of gene marking and gene therapy in oncology clinical trials Cynthia A. Richards
10. Safety testing for gene therapy products J. Patrick Condreay
Index.
Contributors
Preface
1. Introduction: gene therapy approaches to cancer Brian E. Huber
2. Principles of transformation-directed cancer therapy Ian Magrath and Kishor Bhatia
3. Vectors for cancer gene therapy Prem Seth
4. Genetically engineering drug sensitivity and drug resistance for the treatment of cancer Brian E. Huber
5. Oncogene inactivation and replacement strategies for cancer Jack A. Roth
6. Genetically modified tumor cells as tumor vaccines John C. Krauss, Suyu Shu and Alfred E. Chang
7. Genetically modified lymphocytes and hematopoietic stem cells as therapeutic vehicles Patrick J. Geraghty and James J. Mulé
8. Pharmacologic effects of oligonucleotides and some clinical applications Leonard M. Neckers and Kanak Iyer
9. Current status of gene marking and gene therapy in oncology clinical trials Cynthia A. Richards
10. Safety testing for gene therapy products J. Patrick Condreay
Index.
Preface
1. Introduction: gene therapy approaches to cancer Brian E. Huber
2. Principles of transformation-directed cancer therapy Ian Magrath and Kishor Bhatia
3. Vectors for cancer gene therapy Prem Seth
4. Genetically engineering drug sensitivity and drug resistance for the treatment of cancer Brian E. Huber
5. Oncogene inactivation and replacement strategies for cancer Jack A. Roth
6. Genetically modified tumor cells as tumor vaccines John C. Krauss, Suyu Shu and Alfred E. Chang
7. Genetically modified lymphocytes and hematopoietic stem cells as therapeutic vehicles Patrick J. Geraghty and James J. Mulé
8. Pharmacologic effects of oligonucleotides and some clinical applications Leonard M. Neckers and Kanak Iyer
9. Current status of gene marking and gene therapy in oncology clinical trials Cynthia A. Richards
10. Safety testing for gene therapy products J. Patrick Condreay
Index.